PARSECSs: Evaluating the impact of task parallelism in the PARSEC benchmark suite

In this work, we show how parallel applications can be implemented efficiently using task parallelism. We also evaluate the benefits of such parallel paradigm with respect to other approaches. We use the PARSEC benchmark suite as our test bed, which includes applications representative of a wide range of domains from HPC to desktop and server applications. We adopt different parallelization techniques, tailored to the needs of each application, to fully exploit the task-based model. Our evaluation shows that task parallelism achieves better performance than thread-based parallelization models, such as Pthreads. Our experimental results show that we can obtain scalability improvements up to 42% on a 16-core system and code size reductions up to 81%. Such reductions are achieved by removing from the source code application specific schedulers or thread pooling systems and transferring these responsibilities to the runtime system software.This work has been partially supported by the European Research Council under the European Union 7th FP, ERC Grant Agreement number 321253, by the Spanish Ministry of Science and Innovation under grant TIN2012-34557, by the Severo Ochoa Program, awarded by the Spanish Government, under grant SEV-2011-00067 and by the HiPEAC Network of Excellence. M. Moreto has been partially supported by the Ministry of Economy and Competitiveness under Juan de la Cierva post-doctoral fellowship number JCI-2012-15047, and M. Casas is supported by the Secretary for Universities and Research of the Ministry of Economy and Knowledge of the Government of Catalonia and the Co-fund programme of the Marie Curie Actions of the 7th R&D Framework Programme of the European Union (Contract 2013 BP B 00243). Finally, the authors are grateful to the reviewers for their valuable comments, to the people from the Programming Models Group at BSC for their technical support, to the RoMoL team, and to Xavier Teruel, Roger Ferrer and Paul Caheny for their help in this work.Peer ReviewedPostprint (author's final draft

Evaluating the impact of OpenMP 4.0 extensions on relevant parallel workloads

OpenMP has been for many years the most widely used programming model for shared memory architectures. Periodically, new features are proposed and some of them are finally selected for inclusion in the OpenMP standard. The OmpSs programming model developed at the Barcelona Supercomputing Center (BSC) aims to be an OpenMP forerunner that handles the main OpenMP constructs plus some extra features not included in the OpenMP standard. In this paper we show the usefulness of three OmpSs features not currently handled by OpenMP 4.0 by deploying them over three applications of the PARSEC benchmark suite and showing the performance benefits. This paper also shows performance trade-offs between the OmpSs/OpenMP tasking and loop parallelism constructs and shows how a hybrid implementation that combines both approaches is sometimes the best option.This work has been partially supported by the European Research Council under the European Union's 7th FP, ERC Grant Agreement number 321253, by the Spanish Ministry of Science and Innovation under grant TIN2012-34557 and by the HiPEAC Network of Excellence. It has been also supported by the Severo Ochoa Program awarded by the Spanish Government (grant SEV-2011-00067) M. Moreto has been partially supported by the Ministry of Economy and Competitiveness under Juan de la Cierva postdoctoral fellowship number JCI- 2012-15047. M. Casas is supported by the Secretary for Universities and Research of the Ministry of Economy and Knowledge of the Government of Catalonia and the Co- fund programme of the Marie Curie Actions of the 7th R&D Framework Programme of the European Union (Contract 2013 BP_B 00243).Peer ReviewedPostprint (author's final draft

Chronoamperometric Study of Ammonia Oxidation in a Direct Ammonia Alkaline Fuel Cell under the Influence of Microgravity

This is a study of the chronoamperometric performance of the electrochemical oxidation of ammonia in an alkaline fuel cell for space applications. Under microgravity the performance of a fuel cell is diminished by the absence of buoyancy since nitrogen gas is produced. The following catalysts were studied: platinum nanocubes of ca. 10nm, platinum nanocubes on carbon Vulcan ™ and platinum on carbon nanoonion support of ca. 10nm. These nanomaterials were studied in order to search for catalysts that may reduce or counter the loss of ammonia oxidation current densities performance under microgravity conditions. Chronoamperometries at potential values ranging from 0.2 V to 1.2V vs. cathode potential (breathing Air/300ml/min/82737 Pa) in 1.0 M NH4OH (30ml/min in anode) were done during over 30 parabolas in NASA’s C9 airplane The Weightless Wonder in January 2016 from Ellington Field Houston. The current densities at 15s in the chronoamperometry experiments showed diminishing values under microgravity and in some cases improvements of up to 92%, for Pt-carbon nanoonions, and over 70% for the three catalysts versus ground at potentials ranging from 0.2 to 0.4V after 5 minutes of chronoamperometric conditions. At higher potentials, 1.0V or higher, Pt nanocubes and Pt-carbon nanoonions showed enhancements of up to 32% and 24%, respectively. At these higher potentials we will have a contribution of oxygen evolution. The changes in current behavior are attributed to the sizes of the catalyst materials and the time needed for the N2 bubbles detachment from the Pt surface under microgravity conditions.This work was financially supported by the NASA-MIRO Center for Advanced Nanoscale Materials at the University of Puerto Rico-Río Piedras Campus Grant number NNX10AQ17A and NASA-EPSCoR grant number NNX14AN18A, Puerto Rico NASA Space Grant Consortium: NASA cooperative agreement NNX10AM80H, NASA Flight Opportunities Program Announcement of Flight Opportunities (AFO) NOCT110 call #5 and Ministerio de Economía y Competitividad (projects CTQ2013-44083-P and CTQ2013-48280-C3-3-R)

A flagship for Austral temperate forest conservation: an action plan for Darwin's frogs brings key stakeholders together

Darwin’s frogs Rhinoderma darwinii and Rhinoderma rufum are the only known species of amphibians in which males brood their offspring in their vocal sacs. We propose these frogs as flagship species for the conservation of the Austral temperate forests of Chile and Argentina. This recommendation forms part of the vision of the Binational Conservation Strategy for Darwin’s Frogs, which was launched in 2018. The strategy is a conservation initiative led by the IUCN SSC Amphibian Specialist Group, which in 2017 convened 30 governmental, non-profit and private organizations from Chile, Argentina and elsewhere. Darwin’s frogs are iconic examples of the global amphibian conservation crisis: R. rufum is categorized as Critically Endangered (Possibly Extinct) on the IUCN Red List, and R. darwinii as Endangered. Here we articulate the conservation planning process that led to the development of the conservation strategy for these species and present its main findings and recommendations. Using an evidence-based approach, the Binational Conservation Strategy for Darwin’s Frogs contains a comprehensive status review of Rhinoderma spp., including critical threat analyses, and proposes 39 prioritized conservation actions. Its goal is that by 2028, key information gaps on Rhinoderma spp. will be filled, the main threats to these species will be reduced, and financial, legal and societal support will have been achieved. The strategy is a multi-disciplinary, transnational endeavour aimed at ensuring the long-term viability of these unique frogs and their particular habitat

ECMO for COVID-19 patients in Europe and Israel

Since March 15th, 2020, 177 centres from Europe and Israel have joined the study, routinely reporting on the ECMO support they provide to COVID-19 patients. The mean annual number of cases treated with ECMO in the participating centres before the pandemic (2019) was 55. The number of COVID-19 patients has increased rapidly each week reaching 1531 treated patients as of September 14th. The greatest number of cases has been reported from France (n = 385), UK (n = 193), Germany (n = 176), Spain (n = 166), and Italy (n = 136) .The mean age of treated patients was 52.6 years (range 16–80), 79% were male. The ECMO configuration used was VV in 91% of cases, VA in 5% and other in 4%. The mean PaO2 before ECMO implantation was 65 mmHg. The mean duration of ECMO support thus far has been 18 days and the mean ICU length of stay of these patients was 33 days. As of the 14th September, overall 841 patients have been weaned from ECMO support, 601 died during ECMO support, 71 died after withdrawal of ECMO, 79 are still receiving ECMO support and for 10 patients status n.a. . Our preliminary data suggest that patients placed on ECMO with severe refractory respiratory or cardiac failure secondary to COVID-19 have a reasonable (55%) chance of survival. Further extensive data analysis is expected to provide invaluable information on the demographics, severity of illness, indications and different ECMO management strategies in these patients

The evolution of the ventilatory ratio is a prognostic factor in mechanically ventilated COVID-19 ARDS patients

Background: Mortality due to COVID-19 is high, especially in patients requiring mechanical ventilation. The purpose of the study is to investigate associations between mortality and variables measured during the first three days of mechanical ventilation in patients with COVID-19 intubated at ICU admission. Methods: Multicenter, observational, cohort study includes consecutive patients with COVID-19 admitted to 44 Spanish ICUs between February 25 and July 31, 2020, who required intubation at ICU admission and mechanical ventilation for more than three days. We collected demographic and clinical data prior to admission; information about clinical evolution at days 1 and 3 of mechanical ventilation; and outcomes. Results: Of the 2,095 patients with COVID-19 admitted to the ICU, 1,118 (53.3%) were intubated at day 1 and remained under mechanical ventilation at day three. From days 1 to 3, PaO2/FiO2 increased from 115.6 [80.0-171.2] to 180.0 [135.4-227.9] mmHg and the ventilatory ratio from 1.73 [1.33-2.25] to 1.96 [1.61-2.40]. In-hospital mortality was 38.7%. A higher increase between ICU admission and day 3 in the ventilatory ratio (OR 1.04 [CI 1.01-1.07], p = 0.030) and creatinine levels (OR 1.05 [CI 1.01-1.09], p = 0.005) and a lower increase in platelet counts (OR 0.96 [CI 0.93-1.00], p = 0.037) were independently associated with a higher risk of death. No association between mortality and the PaO2/FiO2 variation was observed (OR 0.99 [CI 0.95 to 1.02], p = 0.47). Conclusions: Higher ventilatory ratio and its increase at day 3 is associated with mortality in patients with COVID-19 receiving mechanical ventilation at ICU admission. No association was found in the PaO2/FiO2 variation

Mortality from gastrointestinal congenital anomalies at 264 hospitals in 74 low-income, middle-income, and high-income countries: a multicentre, international, prospective cohort study

Summary Background Congenital anomalies are the fifth leading cause of mortality in children younger than 5 years globally. Many gastrointestinal congenital anomalies are fatal without timely access to neonatal surgical care, but few studies have been done on these conditions in low-income and middle-income countries (LMICs). We compared outcomes of the seven most common gastrointestinal congenital anomalies in low-income, middle-income, and high-income countries globally, and identified factors associated with mortality. Methods We did a multicentre, international prospective cohort study of patients younger than 16 years, presenting to hospital for the first time with oesophageal atresia, congenital diaphragmatic hernia, intestinal atresia, gastroschisis, exomphalos, anorectal malformation, and Hirschsprung’s disease. Recruitment was of consecutive patients for a minimum of 1 month between October, 2018, and April, 2019. We collected data on patient demographics, clinical status, interventions, and outcomes using the REDCap platform. Patients were followed up for 30 days after primary intervention, or 30 days after admission if they did not receive an intervention. The primary outcome was all-cause, in-hospital mortality for all conditions combined and each condition individually, stratified by country income status. We did a complete case analysis. Findings We included 3849 patients with 3975 study conditions (560 with oesophageal atresia, 448 with congenital diaphragmatic hernia, 681 with intestinal atresia, 453 with gastroschisis, 325 with exomphalos, 991 with anorectal malformation, and 517 with Hirschsprung’s disease) from 264 hospitals (89 in high-income countries, 166 in middleincome countries, and nine in low-income countries) in 74 countries. Of the 3849 patients, 2231 (58·0%) were male. Median gestational age at birth was 38 weeks (IQR 36–39) and median bodyweight at presentation was 2·8 kg (2·3–3·3). Mortality among all patients was 37 (39·8%) of 93 in low-income countries, 583 (20·4%) of 2860 in middle-income countries, and 50 (5·6%) of 896 in high-income countries (p<0·0001 between all country income groups). Gastroschisis had the greatest difference in mortality between country income strata (nine [90·0%] of ten in lowincome countries, 97 [31·9%] of 304 in middle-income countries, and two [1·4%] of 139 in high-income countries; p≤0·0001 between all country income groups). Factors significantly associated with higher mortality for all patients combined included country income status (low-income vs high-income countries, risk ratio 2·78 [95% CI 1·88–4·11], p<0·0001; middle-income vs high-income countries, 2·11 [1·59–2·79], p<0·0001), sepsis at presentation (1·20 [1·04–1·40], p=0·016), higher American Society of Anesthesiologists (ASA) score at primary intervention (ASA 4–5 vs ASA 1–2, 1·82 [1·40–2·35], p<0·0001; ASA 3 vs ASA 1–2, 1·58, [1·30–1·92], p<0·0001]), surgical safety checklist not used (1·39 [1·02–1·90], p=0·035), and ventilation or parenteral nutrition unavailable when needed (ventilation 1·96, [1·41–2·71], p=0·0001; parenteral nutrition 1·35, [1·05–1·74], p=0·018). Administration of parenteral nutrition (0·61, [0·47–0·79], p=0·0002) and use of a peripherally inserted central catheter (0·65 [0·50–0·86], p=0·0024) or percutaneous central line (0·69 [0·48–1·00], p=0·049) were associated with lower mortality. Interpretation Unacceptable differences in mortality exist for gastrointestinal congenital anomalies between lowincome, middle-income, and high-income countries. Improving access to quality neonatal surgical care in LMICs will be vital to achieve Sustainable Development Goal 3.2 of ending preventable deaths in neonates and children younger than 5 years by 2030

Tècniques de paral·lelització del simulador Facesim

[CASTELLÀ] Este proyecto hace una evaluación de OmpSs como tecnología para entornos de centros de datos en busca de mejoras en el mantenimiento de aplicaciones así como su eficiencia y costes. Facesim ha sido utilizada como aplicación de pruebas.[ANGLÈS] This project evaluates OmpSs as a technology for datacenters in a research of improvements in application programmability, efficiency and costs. As a test, Facesim has been used

Tècniques de paral·lelització del simulador Facesim

[CASTELLÀ] Este proyecto hace una evaluación de OmpSs como tecnología para entornos de centros de datos en busca de mejoras en el mantenimiento de aplicaciones así como su eficiencia y costes. Facesim ha sido utilizada como aplicación de pruebas.[ANGLÈS] This project evaluates OmpSs as a technology for datacenters in a research of improvements in application programmability, efficiency and costs. As a test, Facesim has been used

Intestinal paracellular absorption is necessary to support the sugar oxidation cascade in nectarivorous bats

We made the first measurements of the capacity for paracellular nutrient absorption in intact nectarivorous bats. Leptonycteris yerbabuenae (20 g mass) were injected with or fed inert carbohydrate probes L-rhamnose and D(+)-cellobiose, which are absorbed exclusively by the paracellular route, and 3-O-methyl-D-glucose (3OMD-glucose), which is absorbed both paracellularly and transcellularly. Using a standard pharmacokinetic technique, we collected blood samples for 2 h after probe administration. As predicted, fractional absorption (f) of paracellular probes declined with increasing Mr in the order of rhamnose (f=0.71)>cellobiose ( f=0.23). Absorption of 3OMD-glucose was complete (f=0.85; not different from unity). Integrating our data with those for glucose absorption and oxidation in another nectarivorous bat, we conclude that passive paracellular absorption of glucose is extensive in nectarivorous bat species, as in other bats and small birds, and necessary to support high glucose fluxes hypothesized for the sugar oxidation cascade.Fil: Rodriguez Peña, Nelly. University of Wisconsin; Estados Unidos. Universidad Autónoma de Tlaxcala; MéxicoFil: Price, Edwin R.. University of Wisconsin; Estados UnidosFil: Caviedes Vidal, Enrique Juan Raul. University of Wisconsin; Estados Unidos. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - San Luis. Instituto Multidisciplinario de Investigaciones Biológicas de San Luis. Universidad Nacional de San Luis. Facultad de Ciencias Físico Matemáticas y Naturales. Instituto Multidisciplinario de Investigaciones Biológicas de San Luis; ArgentinaFil: Flores Ortiz, Cesar M.. Universidad Nacional Autónoma de México; MéxicoFil: Karasov, William H.. University of Wisconsin; Estados Unido